University of Southern California

USC Global Conference

Global Challenges for Humanity
Seoul, Korea
May 23-25, 2013

Andrew P. McMahon

Andrew McMahonAndrew P. McMahon, FRS., is the W.M. Keck provost professor, the director of the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research, and the chairman of the Department of Stem Cell Biology and Regenerative Medicine in the Keck School of Medicine of USC.

McMahon obtained a B.A. in zoology from the University of Oxford (1978) and completed his Ph.D. studies in mammalian genetics in the Medical Research Council’s mammalian development unit at University College London, U.K. (1981).

Andrew McMahon is an elected fellow of the American Association for the Advancement of Science (2000), the American Academy of Arts and Sciences (2003), and the Royal Society, UK (2007); and an elected associate member of the European Molecular Biology Organization (2003). Professor McMahon has also served as an editor of the journals Development and Developmental Biology, on the editorial boards of several other scientific journals, and on numerous scientific advisory groups. His work is published in over 250 referred primary research papers. Professor McMahon has received Javitt’s and Merit Awards from the National Institute of Neurological Disorders and Stroke and the National Institute of Diabetes and Digestive and Kidney Diseases, respectively. Professor McMahon holds over 20 patents principally focused around Hedgehog signaling. He was a scientific co-founder of the biotech company Ontogeny/Curis whose initial work lead to the discovery of small molecule pathway modulators of Hedgehog signaling developed and marketed by Genentech as an approved anti-cancer treatment (Erivedge).

The McMahon group’s research focuses on the regulatory processes that construct, maintain and repair organ systems with a principal focus on the central nervous system, skeleton and kidney.

Confirmed Panelists